Articles with public access mandates - Venugopal GundaLearn more
Available somewhere: 26
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ...
Nature medicine 25 (4), 628-640, 2019
Mandates: US Department of Defense, US National Institutes of Health, German Research …
MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer
SK Shukla, V Purohit, K Mehla, V Gunda, NV Chaika, E Vernucci, RJ King, ...
Cancer cell 32 (1), 71-87. e7, 2017
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
SK Shukla, T Gebregiworgis, V Purohit, NV Chaika, V Gunda, ...
Cancer & metabolism 2, 1-19, 2014
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer
S Tadros, SK Shukla, RJ King, V Gunda, E Vernucci, J Abrego, NV Chaika, ...
Cancer research 77 (20), 5503-5517, 2017
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases
SC Gupta, N Awasthee, V Rai, S Chava, V Gunda, KB Challagundla
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188316, 2020
Mandates: US National Institutes of Health, Department of Science & Technology, India
GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells
J Abrego, V Gunda, E Vernucci, SK Shukla, RJ King, A Dasgupta, ...
Cancer letters 400, 37-46, 2017
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer
CLPKS Venugopal Gunda, Joshua J. Souchek, Jaime Abrego, Surendra K. Shukla ...
Clinical Cancer Research, 2017
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
SK Shukla, A Dasgupta, K Mehla, V Gunda, E Vernucci, J Souchek, ...
Oncotarget 6 (38), 41146, 2015
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism
SK Shukla, V Gunda, J Abrego, D Haridas, A Mishra, J Souchek, ...
Oncotarget 6 (22), 19118, 2015
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
Fascin controls metastatic colonization and mitochondrial oxidative phosphorylation by remodeling mitochondrial actin filaments
S Lin, C Huang, V Gunda, J Sun, SP Chellappan, Z Li, V Izumi, B Fang, ...
Cell reports 28 (11), 2824-2836. e8, 2019
Mandates: US National Institutes of Health
MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
G Goode, V Gunda, NV Chaika, V Purohit, F Yu, PK Singh
PloS one 12 (5), e0176820, 2017
Mandates: US Department of Defense, US National Institutes of Health
Metabolic alterations in pancreatic cancer progression
E Vernucci, J Abrego, V Gunda, SK Shukla, A Dasgupta, V Rai, N Chaika, ...
Cancers 12 (1), 2, 2019
Mandates: US National Institutes of Health
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
RJ King, SK Shukla, C He, E Vernucci, R Thakur, KS Attri, A Dasgupta, ...
Oncogene 41 (7), 971-982, 2022
Mandates: US National Institutes of Health
Validation of metabolic alterations in microscale cell culture lysates using hydrophilic interaction liquid chromatography (HILIC)-tandem mass spectrometry-based metabolomics
V Gunda, F Yu, PK Singh
PloS one 11 (4), e0154416, 2016
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
Inhibition of elastin peptide-mediated angiogenic signaling mechanism (s) in choroidal endothelial cells by the α6 (IV) NC1 collagen fragment
V Gunda, RK Verma, YA Sudhakar
Investigative Ophthalmology & Visual Science 54 (13), 7828-7835, 2013
Mandates: US National Institutes of Health
Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes
CM Moshfegh, CW Collins, V Gunda, A Vasanthakumar, JZ Cao, ...
Redox biology 27, 101141, 2019
Mandates: US National Institutes of Health
Glucose limitation alters glutamine metabolism in MUC1-overexpressing pancreatic cancer cells
T Gebregiworgis, V Purohit, SK Shukla, S Tadros, NV Chaika, J Abrego, ...
Journal of proteome research 16 (10), 3536-3546, 2017
Mandates: US National Institutes of Health, Pancreatic Cancer Action Network, USA
The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities
N Mudgapalli, P Nallasamy, H Chava, S Chava, AS Pathania, V Gunda, ...
Molecular Aspects of Medicine 70, 21-32, 2019
Mandates: US National Institutes of Health, Department of Science & Technology, India
RNA-binding protein HuR regulates both mutant and wild-type IDH1 in IDH1-mutated cancer
M Zarei, S Lal, A Vaziri-Gohar, K O'Hayer, V Gunda, PK Singh, JR Brody, ...
Molecular Cancer Research 17 (2), 508-520, 2019
Mandates: US National Institutes of Health
Amino acids regulate cisplatin insensitivity in neuroblastoma
V Gunda, AS Pathania, S Chava, P Prathipati, NK Chaturvedi, DW Coulter, ...
Cancers 12 (9), 2576, 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program